Search Results - "McFerran, Britta A."

Lack of bioeffects of ultrasound energy after intravenous administration of FS069 (Optison) in the anesthetized rabbit by Killam, A. L, Greener, Y, McFerran, B. A, Maniquis, J, Bloom, A, Widder, K. J, Dittrich, H. C

“…The current study was designed to provide a sensitive in vivo model to maximize the potential bioeffects (measured by hemolysis) of B‐mode ultrasound energy in…”
Get full text

Myocardial contrast echocardiography in experimental coronary artery occlusion with a new intravenously administered contrast agent by Dittrich, H C, Bales, G L, Kuvelas, T, Hunt, R M, McFerran, B A, Greener, Y

“…A new intravenously administered ultrasound contrast agent was studied in eight dogs during intermittent coronary artery occlusion. The area of the myocardial…”
Get more information

955-55 Reproducibility of Myocardial Opacification Using FS069, a New Intravenously Administered Ultrasound Contrast Agent by Dittrich, Howard C., Bales, Gary L., McFerran, Britta A., Kuvelas, Mary T., Hunt, Roberta M.

“…In order for myocardial contrast echocardiography to become clinically useful, ultrasound contrast agents must result in reproducible opacification. We…”
Get full text

Cardiac ultrasound using second harmonics and intravenously administered albumin shell microspheres by Dittrich, Howard C., Killam, Anne L., Rafter, Patrick, Vallance, Anthony G., Kuvelas, Mary T., McFerran, Britta A., Greener, Yigal

Get full text

Tissue Distribution of125 l-LabeIed Albumin in Rats, and Whole Blood and Exhaled Elimination Kinetics of Octafluoropropane in Anesthetized Canines, Following Intravenous Administration of Optison® (FS069) by Killam, Anne L., Mehlhaff, Paige M., Zavorskas, Paul A., Greener, Yigal, McFerran, Britta A., Miller, Jeff J., Burrascano, Cindy, Jablonski, Edward G., Anderson, Leslie, Dittrich, Howard C.

“…OPTISON, an agent being developed as an intravenous (IV) ultrasound contrast agent, consists of a suspension of octafluoro-propane(OFP)-containing albumin…”
Get full text

Tissue Distribution of 125 l-LabeIed Albumin in Rats, and Whole Blood and Exhaled Elimination Kinetics of Octafluoropropane in Anesthetized Canines, Following Intravenous Administration of Optison® (FS069) by Killam, Anne L., Mehlhaff, Paige M., Zavorskas, Paul A., Greener, Yigal, McFerran, Britta A., Miller, Jeff J., Burrascano, Cindy, Jablonski, Edward G., Anderson, Leslie, Dittrich, Howard C.

“…OPTISON, an agent being developed as an intravenous (IV) ultrasound contrast agent, consists of a suspension of octafluoro-propane(OFP)-containing albumin…”
Get full text